Hypopyon

Hypopyon is a medical condition characterized by the presence of pus in the anterior chamber of the eye, between the cornea and the iris. This condition is often a sign of severe inflammation and can be associated with a number of diseases, including uveitis, endophthalmitis, and corneal ulcer.

Causes

Hypopyon is typically caused by an infection or inflammation in the eye. This can occur as a result of a bacterial, viral, or fungal infection, or due to an autoimmune disease such as rheumatoid arthritis or lupus. Other potential causes include trauma to the eye, surgery, or the presence of a foreign body.

Symptoms

The primary symptom of hypopyon is a visible layer of white or yellow pus in the anterior chamber of the eye. This can often be seen without the need for special equipment. Other symptoms may include pain, redness, blurred vision, sensitivity to light, and a decrease in visual acuity.

Diagnosis

Diagnosis of hypopyon typically involves a thorough eye examination, including a slit lamp examination to visualize the anterior chamber of the eye. Additional tests may be performed to determine the underlying cause of the inflammation, such as blood tests, imaging studies, or a biopsy of the eye tissue.

Treatment

Treatment for hypopyon focuses on addressing the underlying cause of the inflammation. This may involve the use of antibiotics, antiviral medications, or antifungal drugs, depending on the nature of the infection. In some cases, corticosteroids may be used to reduce inflammation. In severe cases, surgery may be required to drain the pus from the eye.

Prognosis

The prognosis for hypopyon depends on the underlying cause of the condition. With prompt and appropriate treatment, most cases of hypopyon can be successfully managed. However, if left untreated, hypopyon can lead to serious complications, including vision loss.

See also

• Uveitis
• Endophthalmitis
• Corneal ulcer

Hypopyon Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.